This drug course, known as GLP-one agonists, incorporates semaglutide—accredited as Ozempic for variety 2 diabetes and Wegovy for weight problems—and tirzepatide—approved as Mounjaro for diabetic issues https://declannuin788124.blogdiloz.com/profile